Bausch & Lomb

Bausch boosted ahead of eye spin-off
EP Vantage
Thu, 04/15/21 - 10:09 am
Bausch Health
NOV03
Bausch & Lomb
Drug companies want Supreme Court to take eye drop dispute
Yahoo/AP
Sat, 03/31/18 - 09:55 am
eye drops
eye health
Supreme Court
Allergan
Bausch & Lomb
Merck
Pfizer
Bausch & Lomb Continues to be Key Growth Driver for Valeant
Market Realist
Sat, 03/25/17 - 11:57 am
Bausch & Lomb
Valeant Pharmaceuticals
Valeant: Is Bausch & Lomb The Next To Fall?
Seeking Alpha
Tue, 01/17/17 - 10:08 pm
Valeant Pharmaceuticals
Bausch & Lomb
More Valeant up for bid? Beseiged pharma weighs $2.5B sale of eye-surgery biz
Fierce Pharma
Thu, 11/3/16 - 09:52 am
Valeant Pharmceuticals
M&A
Bausch & Lomb
eye surgery
Debt-laden Valeant can't afford to say 'never' to selling off Bausch & Lomb, CEO says
Fierce Pharma
Thu, 09/8/16 - 06:35 pm
Valeant Pharmaceuticals
M&A
Bausch & Lomb
Valeant subsidiary discloses subpoena over doctor payments
Medical Marketing and Media
Mon, 10/26/15 - 04:34 pm
Valeant Pharmaceuticals
Bausch & Lomb
physician payments
Valeant's Bausch + Lomb Announces Results on Lotemax
Yahoo/Zacks.com
Tue, 09/30/14 - 11:41 am
Valeant Pharmaceuticals
Bausch & Lomb
Lotemax
cataract surgery
Nicox to co-promote eye drug with Bausch + Lomb in the US
Yahoo/Reuters
Fri, 08/8/14 - 08:43 am
NicOx
Bausch & Lomb
Valeant Pharmaceuticals
latanoprostene
Drugmaker Valeant touts Bausch + Lomb growth to Allergan investors
Yahoo/Reuters
Sat, 07/19/14 - 12:02 am
Valeant Pharmaceuticals
M&A
Bausch & Lomb
Allergan
J&J Fined With Rivals in China Lens Price-Fixing Case
Bloomberg
Mon, 06/2/14 - 09:28 am
JNJ
price fixing
Bausch & Lomb
Top 10 Pharma M&A deals of 2013
Fierce Pharma
Thu, 04/17/14 - 08:29 am
M&A
Amgen
ONYX Pharmaceuticals
Bausch & Lomb
Valeant Pharmaceuticals
Elan
Perrigo
Actavis
Warner Chilcott
Bristol-Myers Squibb
AstraZeneca
Pearl Therapeutics
Agila
Mylan
Salix
Santarus
Bayer
Algeta
Shire
ViroPharma
Valeant Targets Corporate ‘Fat’ in Push for Big Leagues
Bloomberg
Thu, 03/20/14 - 09:31 am
Valeant Pharmaceuticals
Mike Pearson
restructuring
Bausch & Lomb
M&A
Valeant swings to profit on Bausch & Lomb buy
Yahoo/Reuters
Thu, 02/27/14 - 08:17 am
Valeant Pharmaceuticals
earnings
Bausch & Lomb
With $29B in deals so far, 2013 shaping up as big M&A year
Fierce Pharma
Fri, 09/20/13 - 10:23 am
M&A
Valeant Pharmaceuticals
Bausch & Lomb
ONYX Pharmaceuticals
Amgen
Forest Labs Picks Former Bausch Leader Saunders as its CEO
Bloomberg
Tue, 09/10/13 - 10:27 am
Pharma CEOs
Bausch & Lomb
Forest Labs
Brenton Saunders
Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch + Lomb
Yahoo
Tue, 08/6/13 - 11:27 am
M&A
Bausch & Lomb
Valeant Pharmaceuticals
Valeant CEO Blasted By NY Pols For Moving Bausch + Lomb HQ
Pharmalot
Fri, 08/2/13 - 11:00 am
Valeant Pharmaceuticals
Bausch & Lomb
Valeant To Cut To 2,850 Workers After Bausch + Lomb Deal
Pharmalot
Mon, 07/29/13 - 01:35 pm
Valeant Pharmaceuticals
layoffs
Bausch & Lomb
M&A
China Biotech In Review: Valeant Pharma Gains Sales Foothold In China With Bausch & Lomb Buy
Seeking Alpha
Sun, 06/2/13 - 11:49 am
Valeant Pharmaceuticals
Bausch & Lomb
BeiGene
Merck Serono
Winteam Pharma
Tongjitang Chinese Medicines
Qiagen
Aslan Pharma
Sinovac Biotech
Vigoo Biological

Pages